Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6796 vs ABT, SYK, MDT: Buyback Yield % Comparison
For the Medical Devices subindustry, Medimaging Integrated Solution's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medimaging Integrated Solution Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medimaging Integrated Solution's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Medimaging Integrated Solution's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medimaging Integrated Solution (TPE:6796) has a Buyback Yield % of 0.00 as of Jul. 15, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Medimaging Integrated Solution and its competitors. According to the industry distribution chart, Medimaging Integrated Solution ranks #999999 out of 347 companies in the Medical Devices & Instruments industry.
Is Medimaging Integrated Solution's Buyback Yield % too high?
Medimaging Integrated Solution's current Buyback Yield % is 0.00. Based on the distribution chart, Medimaging Integrated Solution ranks #999999 out of 347 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medimaging Integrated Solution has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medimaging Integrated Solution's Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medimaging Integrated Solution ranks #999999 out of 347 companies for Buyback Yield %. This places Medimaging Integrated Solution in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Medimaging Integrated Solution and its competitors. Medimaging Integrated Solution's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medimaging Integrated Solution stock overvalued right now?
Based on GuruFocus' analysis, Medimaging Integrated Solution (TPE:6796) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$106.51, compared to a current price of NT$57.70 — trading 45.8% below its estimated fair value. The current Buyback Yield % is 0.00. Medimaging Integrated Solution's overall GF Score™ is 74/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Medimaging Integrated Solution (TPE:6796), the current Buyback Yield % is 0.00 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medimaging Integrated Solution (TPE:6796) Overvalued in 2026?
Based on GuruFocus' analysis, Medimaging Integrated Solution stock appears to be undervalued.
The current stock price of NT$57.70 is trading 45.8% below its estimated GF Value™ of NT$106.51.
GuruFocus considers Medimaging Integrated Solution to be Significantly Undervalued.
Key valuation signals for TPE:6796:
Buyback Yield %: 0.00
GF Value™: NT$106.51 vs. price of NT$57.70 (45.8% below fair value)
No single metric tells the full story. See the TPE:6796 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medimaging Integrated Solution Business Description
Medimaging Integrated Solution Inc and its subsidiaries are engaged in the design, manufacturing, and sales of digital medical imaging diagnostic equipment and related products and services. The company is a trusted partner of hospitals, medical schools, and health organizations, providing practitioners with digital and portable diagnostic solutions. The company designs and manufactures digital hand-held diagnostic scopes. Its products include Horus Scope, Smart Solutions, Endoscopy, and Micro Camera Modules.
74GF Score
Get the complete analysis for TPE:6796
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6796 has been successfully added to your 
